Publication: Vedolizumab treatment in patient with Xla, is it safe and efficient?
dc.contributor.author | Çekiç, Şükran | |
dc.contributor.author | Özgür, Taner | |
dc.contributor.author | Karalı, Yasin | |
dc.contributor.author | Özkan, Tanju Başarır | |
dc.contributor.author | Kılıç, S. S. | |
dc.contributor.buuauthor | ÇEKİÇ, ŞÜKRÜ | |
dc.contributor.buuauthor | ÖZGÜR, TANER | |
dc.contributor.buuauthor | KARALI, YASİN | |
dc.contributor.buuauthor | ÖZKAN, TANJU MUNEVVER | |
dc.contributor.buuauthor | Kılıç, S. S. | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Gastroenteroloji Bilim Dalı | |
dc.contributor.orcid | 0000-0002-9574-1842 | |
dc.contributor.orcid | 0000-0001-8571-2581 | |
dc.contributor.researcherid | AAG-8381-2021 | |
dc.contributor.researcherid | AAH-1658-2021 | |
dc.contributor.researcherid | GBO-8694-2022 | |
dc.contributor.researcherid | FFS-1974-2022 | |
dc.contributor.researcherid | IGX-1808-2023 | |
dc.date.accessioned | 2024-07-23T10:33:26Z | |
dc.date.available | 2024-07-23T10:33:26Z | |
dc.date.issued | 2018-08-01 | |
dc.description | Bu çalışma, 26-30, Mayıs 2018 tarihlerinde Munich[Almanya]’da düzenlenen Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) Kongresi‘nde bildiri olarak sunulmuştur. | |
dc.description.sponsorship | European Acad Allergy & Clin Immunol | |
dc.identifier.eissn | 1398-9995 | |
dc.identifier.endpage | 769 | |
dc.identifier.issn | 0105-4538 | |
dc.identifier.startpage | 768 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/journal/13989995 | |
dc.identifier.uri | https://hdl.handle.net/11452/43380 | |
dc.identifier.volume | 73 | |
dc.identifier.wos | 000441690405197 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.journal | Allergy | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Allergy | |
dc.subject | Immunology | |
dc.subject | Allergy | |
dc.subject | Immunology | |
dc.title | Vedolizumab treatment in patient with Xla, is it safe and efficient? | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | ca52bf41-6be5-42a5-b2c5-f219305eba24 | |
relation.isAuthorOfPublication | 84d11a1f-8e67-4a45-a1b0-d5cd72103f80 | |
relation.isAuthorOfPublication | 0a2bfa05-0e6e-4f99-ae52-704e9dc7a4f5 | |
relation.isAuthorOfPublication | 6609ed9a-b9d8-4f0e-9551-ce0f8524ff95 | |
relation.isAuthorOfPublication.latestForDiscovery | ca52bf41-6be5-42a5-b2c5-f219305eba24 |